Tebentafusp-tebn With LDT in Metastatic UM

Clinical trial NCT06626516 · RECRUITING

Trial details

NCT number: NCT06626516
Sponsor: Thomas Jefferson University
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Uveal Melanoma

Start date: 2025-10-15
Primary completion: 2030-10-01
Enrollment: 109

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.